Insights from therapeutic studies for PrP prion disease

研究成果: Article査読

28 被引用数 (Scopus)


Although an effective therapy for prion disease has not yet been established, many advances have been made toward understanding its pathogenesis, which has facilitated research into therapeutics for the disease. Several compounds, including flupirtine, quinacrine, pentosan polysulfate, and doxycycline, have recently been used on a trial basis for patients with prion disease. Concomitantly, several lead antiprion compounds, including compound B (compB), IND series, and anle138b, have been discovered. However, clinical trials are still far from yielding significantly beneficial results, and the findings of lead compound studies in animals have highlighted new challenges. These efforts have highlighted areas that need improvement or further exploration to achieve more effective therapies. In this work, we review recent advances in prion-related therapeutic research and discuss basic scientific issues to be resolved for meaningful medical intervention of prion disease.

ジャーナルCold Spring Harbor Perspectives in Medicine
出版ステータスPublished - 2017 3月

ASJC Scopus subject areas

  • 生化学、遺伝学、分子生物学(全般)


「Insights from therapeutic studies for PrP prion disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。